Literature DB >> 27757757

Mammalian Actins: Isoform-Specific Functions and Diseases.

Christophe Ampe1, Marleen Van Troys2.   

Abstract

Actin is the central building block of the actin cytoskeleton, a highly regulated filamentous network enabling dynamic processes of cells and simultaneously providing structure. Mammals have six actin isoforms that are very conserved and thus share common functions. Tissue-specific expression in part underlies their differential roles, but actin isoforms also coexist in various cell types and tissues, suggesting specific functions and preferential interaction partners. Gene deletion models, antibody-based staining patterns, gene silencing effects, and the occurrence of isoform-specific mutations in certain diseases have provided clues for specificity on the subcellular level and its consequences on the organism level. Yet, the differential actin isoform functions are still far from understood in detail. Biochemical studies on the different isoforms in pure form are just emerging, and investigations in cells have to deal with a complex and regulated system, including compensatory actin isoform expression.

Entities:  

Keywords:  Actin disease mutation; Actin genes; Baraitser-Winter syndrome; Cytoskeleton; Deafness; Isoform switching; Myopathy; Thoracic aortic aneurysms and dissection

Mesh:

Substances:

Year:  2017        PMID: 27757757     DOI: 10.1007/164_2016_43

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  13 in total

Review 1.  Regulation of actin isoforms in cellular and developmental processes.

Authors:  Anna S Kashina
Journal:  Semin Cell Dev Biol       Date:  2020-01-27       Impact factor: 7.727

Review 2.  The makings of the 'actin code': regulation of actin's biological function at the amino acid and nucleotide level.

Authors:  Pavan Vedula; Anna Kashina
Journal:  J Cell Sci       Date:  2018-05-08       Impact factor: 5.285

Review 3.  Targeting the cytoskeleton against metastatic dissemination.

Authors:  Carmen Ruggiero; Enzo Lalli
Journal:  Cancer Metastasis Rev       Date:  2021-01-20       Impact factor: 9.264

Review 4.  Cytoplasmic Beta and Gamma Actin Isoforms Reorganization and Regulation in Tumor Cells in Culture and Tissue.

Authors:  V B Dugina; G S Shagieva; P B Kopnin
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

5.  Essential nucleotide- and protein-dependent functions of Actb/β-actin.

Authors:  Xiaobai Patrinostro; Pallabi Roy; Angus Lindsay; Christopher M Chamberlain; Lauren J Sundby; Colby G Starker; Daniel F Voytas; James M Ervasti; Benjamin J Perrin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-16       Impact factor: 11.205

6.  Prevalence of Cytoplasmic Actin Mutations in Diffuse Large B-Cell Lymphoma and Multiple Myeloma: A Functional Assessment Based on Actin Three-Dimensional Structures.

Authors:  Laura Witjes; Marleen Van Troys; Bruno Verhasselt; Christophe Ampe
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

7.  Knockout of ACTB and ACTG1 with CRISPR/Cas9(D10A) Technique Shows that Non-Muscle β and γ Actin Are Not Equal in Relation to Human Melanoma Cells' Motility and Focal Adhesion Formation.

Authors:  Natalia Malek; Ewa Mrówczyńska; Aleksandra Michrowska; Ewa Mazurkiewicz; Iuliia Pavlyk; Antonina Joanna Mazur
Journal:  Int J Mol Sci       Date:  2020-04-15       Impact factor: 5.923

8.  Fundamental differences.

Authors:  Peter W Gunning; Edna C Hardeman
Journal:  Elife       Date:  2018-02-01       Impact factor: 8.140

9.  Lymphocyte-specific protein 1 regulates mechanosensory oscillation of podosomes and actin isoform-based actomyosin symmetry breaking.

Authors:  Pasquale Cervero; Christiane Wiesner; Anais Bouissou; Renaud Poincloux; Stefan Linder
Journal:  Nat Commun       Date:  2018-02-06       Impact factor: 14.919

10.  Three mammalian tropomyosin isoforms have different regulatory effects on nonmuscle myosin-2B and filamentous β-actin in vitro.

Authors:  Salma Pathan-Chhatbar; Manuel H Taft; Theresia Reindl; Nikolas Hundt; Sharissa L Latham; Dietmar J Manstein
Journal:  J Biol Chem       Date:  2017-11-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.